Objective: To provide an updated review on extrahepatic biliary atresia, focusing mainly on its etiopathogenesis, diagnosis, treatment and prognosis.
Introduction
Extrahepatic biliary atresia (EHBA), characterized by obliteration or discontinuity of extrahepatic bile ducts, is still the major cause for liver transplantation among children nowadays. 1 Despite the amount of effort put in by researchers worldwide, surgery -Kasai portoenterostomy and its modifications -is the only available treatment. 2 All untreated children eventually die due to complications resulting from portal hypertension and liver cirrhosis, and most treated children have to undergo liver transplantation. 3 The exchange and diffusion of information that can make the diagnosis of EHBA easier is of utmost importance, since Table 1 .
Based on the period in which atresia occurs, it may be classified as embryonic or fetal and perinatal. The embryonic form accounts for 20% of cases. 9 In this form, the extrahepatic biliary tree might have undergone abnormal morphogenesis and is often associated with non-hepatic structural anomalies. 10 The polysplenia syndrome is the most common anomaly, being found in 8 to 12% of patients with atresia and is characterized by polysplenia/asplenia associated with a midline liver, interruption of the inferior vena cava, preduodenal portal vein, situs inversus and/or intestinal malrotation. 9 Other congenital malformations can be observed, such as cardiac anomalies, annular pancreas, immotile cilia syndrome, duodenal atresia, esophageal atresia, polycystic kidney disease, cleft palate and jejunal atresia.
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In the perinatal form, bile ducts are patent at birth, but an inflammatory and sclerosing reaction, caused by perinatal injury, results in the obstruction of the biliary tree. 7 This form accounts for 80% of cases of atresia, but it is not usually associated with malformations.
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Etiopathogenesis of extrahepatic biliary atresia
In 1885, atresia was reported as an autopsy finding 12 and, despite numerous studies since then, its etiopathogenesis has not been fully determined yet. The application of immunology, genetics, and animal models to study biliary atresia have begun unraveling the contribution of infectious, immune, autoimmune, genetic, epigenetic, vascular and morphogenic processes in the pathophysiology of biliary obstruction.
Infectious processes
The seasonal oscillation in the incidence of atresia, shown by Yoon et al., led to the assumption that atresia could be caused by environmental factors, probably by a virus, in the perinatal period. 5 However, the seasonal pattern of this disease was not confirmed by subsequent studies. 13 Nevertheless, a great deal of effort has been put in the isolation of hepatotropic viruses from children with biliary atresia. The presence of hepatitis B virus was reported in Japan, 14 but not confirmed by Balistreri et al. 
in the United
States. 15 Other pathogens have also been identified in patients with atresia, such as human papillomavirus, 16 respiratory syncytial virus, 17 herpes virus, 18 cytomegalovirus (CMV), 19 reovirus type 3 20 and rotavirus. 21 Of these, the latter three have received greater attention.
With regard to CMV, Tarr et al. assessed 23 patients with biliary atresia using liver histology, serology and culture and found five (24%) CMV-positive patients. 22 Likewise, a
Brazilian study detected positive IgM for CMV in 28.5% of patients with EHBA or choledochal cyst. 23 Fischler et al.
detected CMV DNA in the liver of 50% of children with atresia whose mothers were CMV-positive. 19 However, these findings were not confirmed by other researchers, who did not find CMV in the biliary remnants of patients with atresia.
24 Table 1 -Classification of EHBA according to the site of extrahepatic biliary obstruction.
Type Prevalence Characteristics
Type 1~5% Obliteration of the common bile duct, while proximal ducts are patent. The gallbladder usually contains bile.
Type 2~3% Atresia of hepatic ducts; the gallbladder does not contain bile and the transection of proximal remnants shows two distinct bile duct lumens.
Type 3 > 90% Atresia involving the right and left hepatic ducts. Obstruction to the level of the porta hepatis. Absence of proximal lumens at the porta hepatis.
Reovirus was associated with biliary atresia when the virus caused similar signs and symptoms in weaning mice. 25 Later, Morecki et al. reported a high prevalence of positive serologic results for reovirus in patients with atresia, 20 but this finding was not replicated in a subsequent study. 26 The presence of reovirus in liver tissue and bile ducts, detected by polymerase chain reaction (PCR), in patients with atresia or choledochal cysts, 27 provided striking evidence of a potential role of reovirus in the development of atresia.
Similarly to reovirus, rotavirus has been investigated as etiologic agent of EHBA, after group A rotavirus inoculation was found to induce EHBA in newborn mice, 28 and murine models have then been used by several of the currently available studies. 29 However, discrepant results regarding the presence of this virus in infants with atresia were described in other studies. 21, 30 Thus, no study so far has managed to definitively prove the role of a specific virus as etiologic agent of EHBA, or to explain why some viruses, which affect millions of children, cause bile duct injury in only a small percentage of them. One alternate or complementary biological process that may participate in virus-induced injury to the biliary system in the pathogenesis of biliary atresia is immune dysfunction.
Immune dysfunction
The role of immune dysfunction has been based upon the assumption that the biliary epithelium may express inappropriate antigens on its surface that can be recognized by lymphocytes after viral or toxic damage. There could be an immune cascade, which could produce inflammation and biliary fibrosis. 
Autoimmunity
The progressive nature of liver injury in patients with atresia, the presence of lymphocytes in the liver and the association with certain types of HLA suggest a possibly autoimmune, persistent attack against the bile ducts. 42 As to the prevalence of HLA, Silveira et al. found a high prevalence of HLA-B12 and of A9-B5 and A28-B35 haplotypes in children with atresia, especially in those without associated malformations. 43 However, a Spanish study did not show any differences in HLA I and II between atresia patients and healthy children. 44 
Genetics and hepatic morphogenesis
Atresia is not believed to be an inherited disease, but genetic factors might be involved in its pathogenesis. Reports of familial cases 47, 48 provide evidence in favor of this hypothesis, although the risk of familial recurrence is extremely low. The behavior among different races also plays a role, since according to an epidemiological study, the incidence of atresia was 5.7 times higher in Polynesia than in metropolitan France. 13 The most widely investigated genes are those related to laterality (inversin) and to the development of bile ducts. In this context, the association of embryonic atresia with the polysplenia syndrome shows possible laterality defects during embryogenesis, 49 which motivated studies about the genes involved in the laterality of inv mice. In these mice, a spontaneous mutation in the inversin gene, on chromosome 4, resulted in total abdominal situs inversus, obstructive jaundice and death in the first week of life. 50 The detailed analysis of the hepatobiliary system of inv mice revealed extrahepatic biliary obstruction and intrahepatic ductular proliferation. 51 Nevertheless, the lack of inflammation or necrosis in the liver parenchyma of these mice is not compatible with the histological characteristics observed in infants with biliary atresia.
Moreover, the human inversin gene was mapped on chromosome 9q, and no mutation in this gene was detected in a case series of patients with biliary atresia and laterality defects. 52 Another gene that may play a role in EHBA is Jag-1, 53 although its influence on the development of atresia has not been definitively confirmed. Recently, the genetic inactivation of hepatocyte nuclear factors (HNF), such as HNF-1β 54 and HNF6, 55 has caused morphological anomalies in intrahepatic bile ducts and in the gallbladder. HNF-1β was associated with paucity of intrahepatic bile ducts, whereas HNF6 was related to ductal plate malformation and to the presence of intrahepatic cysts, 56 as shown in Table 2 .
Altogether, these data suggest that mutations in the genes that regulate hepatobiliary development may play a role in extrahepatic biliary atresia, but the implication of these specific genes in the pathogenesis of atresia in humans remains unclear. Another pending question is how ductal plate malformation may lead to EHBA.
Epigenetic factors
The role of epigenetic factors in the pathogenesis of atresia was assessed by Zhang et al. in a study that investigated a transcriptome of children with either perinatal or embryonic atresia. 57 These authors found an increased expression of genes related to chromatin regulatory factors (SMARCA-1, HDAC3 and RYBP). 57 Because these genes influence epigenetic processes, the authors speculated a potential role for epigenetic factors on the pathogenesis of bile duct obstruction. Table 3 summarizes the major mechanisms involved in the pathogenesis of biliary atresia, and Figure 2 shows the interaction between these different mechanisms.
Clinical picture
The clinical signs that characterize EHBA are jaundice, acholic stools, choluria and hepatomegaly, which are observed both in the embryonic and perinatal forms.
However, the age of onset and the presence of associated symptoms allow for the differentiation between the two clinical forms.
Children with the embryonic form of atresia usually have 
Diagnosis
The differential diagnosis encompasses a long and heterogeneous list of diseases 61 (Table 4 ). In many of them, such as atresia, long-term survival and quality of life depend on early treatment. Therefore, neonatal cholestasis can be seen as a pediatric gastroenterological emergency.
In the evaluation of the infant with cholestasis, the first step is to define whether jaundice is secondary to an for the diagnosis of atresia. 7 However, an array of clinical, laboratory, imaging and histological information should be assessed together, in order to select the patients who are going to be submitted to laparotomy.
As expected, from the laboratory standpoint, the patients show an increase in total bilirubin (TB), with predominance of direct bilirubin (DB) or conjugated bilirubin. Nonetheless, interestingly, TB is seldom greater than 12 mg/dL, and may be as low as 5 to 8 mg/dL; and DB is often lower than 8 mg/dL, despite total obstruction of bile ducts. 9 With regard to liver enzymes, the levels of gamma-glutamyl transferase (GGT) and alkaline phosphatase (AF) are higher than hepatocellular enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Special attention should be paid to GGT, since AF is originated in bones. 63 The elevation of bile acids is universal in these patients. 9 Liver function, assessed by albumin and clotting function, is normal in the initial stages of the disease, and hypoalbuminemia and coagulopathy may be observed in patients with end-stage cirrhosis. Importantly, the international normalized ratio (INR) may be abnormal due to vitamin K deficiency. cholestasis. 67 According to this algorithm, patients with the triangular cord sign should be referred to intraoperative cholangiography, whereas those patients in which the triangular cord is not identified should be submitted to liver biopsy. 67 It should be highlighted that the absence of this sign is not sufficient to rule out the diagnosis of EHBA.
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Echography also plays an important role in the assessment of associated anomalies, such as polysplenia, and of other diagnostic possibilities, such as choledochal cyst. It should be recalled that cysts of the extrahepatic biliary tree may be observed in 5% of patients with atresia. Some cysts contain mucus, whereas others contain bile. 11 The latter finding may be mistaken for the diagnosis of true choledochal cyst, which may be established with (percutaneous or surgical)
cholangiogram.
Technetium-99m diisopropyl iminodiacetic acid (Tc-99m DISIDA) scintigraphy is of limited value. In cases in which a radiotracer is detected in the intestine, one may say that bile ducts are patent, which rules out the possibility of bile duct obstruction. However, failed excretion of the isotope into the intestine, with its urinary elimination, has a specificity of 50 to 75% for the diagnosis of atresia, despite a high sensitivity (95%). This is because cholestatic parenchymal diseases may have the same pattern. The patient's age is a key factor that influences response to portoenterostomy. Satisfactory biliary drainage is observed in up to 80% when the patient is submitted to early portoenterostomy, whereas this rate is around 10 to 20% in infants operated at 4 months of life. 76 In addition to patient's age at portoenterostomy, some postoperative complications may influence outcome in children.
Complications
During the course of the disease, children may present with complications from the disease itself, such as the consequences of chronic cholestasis (steatorrhea, malnutrition, fat-soluble vitamin deficiency, delayed neuropsychomotor development, jaundice, pruritus, portal hypertension and secondary biliary cirrhosis), as well as those related to portoenterostomy (ascending cholangitis), 9 as shown in However, the patient may present with only a sudden onset of jaundice or acholic stools, without other signs or symptoms.
Thus, a high suspicion should be present so as to allow for early diagnosis. Obviously, other potential sources of infection, such as urinary tract and respiratory tract infections, should be carefully considered. 80 There is a high frequency of febrile diseases in children (e.g.: those caused by viruses), and bacterial cholangitis may occur during or these infections because of the lack of protective factors normally present in the bile flow. Therefore, it is not always an easy task to determine whether the symptoms are due to an unrelated infection or with bacterial cholangitis. It has been therefore recommended that the combination of fever, lighter color of the stools, jaundice and/or abnormalities in liver enzymes in the first postoperative year should be treated as cholangitis. 9 Furthermore, if after 24 to 48 h of antibiotic therapy, the patient does not show clinical and/or laboratory improvement, the use of corticosteroids, such as methylprednisolone for 5 days 9 should be considered. As to laboratory findings, episodes of cholangitis include leukocytosis, increased levels of DB, aminotransferases, GGT and AF; it should be recalled, however, that after portoenterostomy, the serum levels of these enzymes usually escalate 1 to 5 times above normal values. Consequently, a patient with bacterial cholangitis shows enzyme levels above the previous levels of enzymes for individual patients.
Diagnostic confirmation may be obtained by blood culture and liver histology, but treatment should be initiated immediately, often before any of these results are available. 8 Treatment consists of broad-spectrum antibiotic therapy, which is effective against gram-negative bacteria and enteric microorganisms. Empirical treatment with ceftriaxone is recommended. 80 Sulfamethoxazole and trimethoprim or neomycin are efficient prophylactic agents, with no difference between these drugs. 81 Refractory cholangitis may develop in some patients, in whom multiple parenchymal cysts can be observed, which are correlated with a dismal prognosis. 82 In these cases, the prolonged use of parenterally-administered antibiotics is indicated when signs of infection are observed, 82 and the indication for aspiration or drainage should be assessed. 83 Portal hypertension is the second most frequent complication of atresia. Its presence depends on the degree EHBA = extrahepatic biliary atresia. of liver fibrosis at portoenterostomy and on its response to portoenterostomy. 84 In infants without good drainage, the progression of fibrosis is quick. In these cases, varices develop early in the first year of life. Infants with satisfactory biliary drainage may present with fibrosis and portal hypertension, but this usually occurs later. 9 During the course of the disease, the patient may have collateral circulation, splenomegaly, hypersplenism, ascites, spontaneous bacterial peritonitis, upper gastrointestinal bleeding due to the rupture of esophageal and/or gastric varices, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome and liver failure. 9 Delayed psychomotor development is observed in patients who present with progressive chronic liver disease.
It is apparently associated with malnutrition, and in order to avoid this undesirable consequence, nutritional support should be maintained and liver transplantation should be indicated before the disease reaches an advanced stage. 85 Pruritus may be present, although it is not intense as in other diseases, such as progressive familial intrahepatic cholestasis. The most common therapeutic options include ursodeoxycholic acid 86 and rifampicin. 87 As shown in Figure   6 , rifampicin increases bilirubin secretion by inducing glucuronyl-transferase (UGT1A1) and bilirubin glucuronide carrier protein (MDR2). Since rifampicin induces CYP3A4, it makes the conversion of hydrophobic bile acids into hydrophilic compounds easier, which then undergo conjugation followed by excretion through MDR3.
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Ursodeoxycholic acid increases the expression of several carriers, including BSEP, MDR3 and MRP4, which act upon the excretion of bile acids, phospholipids and conjugated organic anions, respectively.

Management of patients after portoenterostomy
After portoenterostomy, the aim of therapeutic measures is to mitigate complications, promoting good nutritional status, stimulating choleresis, preventing infections (cholangitis) and persistent inflammation.
Nutritional therapy
The first step consists of nutritional assessment, considering the triceps skinfold and arm circumference. 89 Of note, weight is not the best parameter in patients with chronic liver diseases, since visceromegaly and ascites may shroud malnutrition.
Maintaining the nutritional status is essential to a good outcome, but it is a challenge, mainly in cholestatic children with progressive liver disease. In these children, 
Ursodeoxycholic acid
Ursodeoxycholic acid is routinely used to promote choleresis, as an attempt to avert fibrosis and progression of liver disease. 86 There are no studies confirming the efficacy of ursodeoxycholic acid, but as it is well-tolerated and offers potential benefits, as shown in Figure 6 . Therefore, it is often used in the dose of 10 to 20 mg/kg/day.
Antibiotics
The 
Steroids
The remarkable inflammatory process observed at the porta hepatis raised the hypothesis that immune mechanisms may play a role in the pathogenesis and progression of the disease after surgery, which motivated studies that assess the use of steroids in an attempt to prevent inflammatory cholangitis; to minimize intrahepatic bile duct injuries; to maintain the bile flow; and to reduce progression to fibrosis. 9 In a retrospective review, the use of corticoid therapy for 8 to 10 weeks after surgery seemingly improved the outcome, when compared to historical controls. 91 The use of steroids for a short time period, for 1 to 2 weeks after surgery, has also been recommended by some authors. 92 With regard to the dose, Kobayashi et al. have recently stated that high doses of prednisolone are associated with better biliary drainage, since patients were jaundice-free much earlier and remained so for a longer time. 93 However, no randomized controlled trials have been published so far confirming the benefit of steroids in patients with atresia; meanwhile, patients receiving corticosteroids must be carefully followed up in order to avoid side effects, such as excessive irritability, hypertension, opportunistic infections, among others.
Prognosis and liver transplantation
Prognosis depends on the treatment used and on the Thus, the follow-up of patients should be rigorous, as there may be progression of liver injury to cirrhosis, despite satisfactory biliary drainage.
Factors that influence prognosis are the following:
patient's age at the time of surgery; extension of liver fibrosis at surgery; degree of intrahepatic bile duct injury; number of episodes of ascending cholangitis; surgeon's expertise; site of bile duct obstruction; and the type of atresia (embryonic or fetal). 9 As to age, the patients submitted to the Kasai procedure at an early age (< 60 days) have a better prognosis, 79, 95 as shown in Table 5 .
After the third month of life, Kasai portoenterostomy is still indicated, because even with a lower success rate, the need for liver transplantation can be postponed. maintain liver function in the presence of progression to cirrhosis in more peripheral areas. 99 As far as the site of biliary tree obstruction is concerned, patients with proximal patent bile ducts and distal obstruction (type I atresia) have a better prognosis than those with proximal atresia extending into the porta hepatis. 100, 101 Patients with embryonic atresia seem to have a worse prognosis when compared to those with the perinatal form of the disease. 95 The unsatisfactory outcome of children submitted to Kasai portoenterostomy at an age less than 30 days probably reflects the different pathogenesis of embryonic or fetal atresia. 102 Agenesis of bile ducts, which possibly results from primary agenesis of the hepatic diverticulum, is rare and requires liver transplantation, even before portoenterostomy. 103 In terms of predictive factors, TB levels in the postoperative period are an excellent predictor of long-term survival. 104 Levels below 1.0 mg/dL, within 3 months after the surgery, correlate with good prognosis, and the necessity for future transplantation is unlikely. 105 This finding has a significant practical value, since it may help identify patients who need more intensive drug therapy and nutritional support during the progression of the disease.
Despite the great advances in pediatric hepatology in the last few years, only 11% of adolescents and young adults with atresia submitted to portoenterostomy show minimal signs of chronic liver disease, and are therefore regarded as "cured." Improvements in transplantation techniques and the appropriate referral of patients allow for a striking increase in the survival rate. 106 Currently, the long-term survival of transplant recipients with atresia corresponds to 80 to 90%. 9 If, on the one hand, treatments for atresia have not been greatly improved, on the other hand, liver transplantation has become an effective treatment for pediatric patients 106 due to improvements in surgical techniques and in immunosuppressive regimens.
Referral of patients to specialized centers
The aspects described here highlight the importance of early referral of these children to specialized centers, but this does not usually happen. The possibility of physiologic or breastmilk jaundice may hinder and delay diagnosis, except if bilirubin levels are measured in order to detect direct hyperbilirubinemia. 11 Even in industrialized countries, 14 to 29% of patients with biliary atresia are referred for assessment only after the third month of life. 76, 79 Therefore, every patient with jaundice should be assessed after 14 days of life, 107 since at this age, the diagnosis of physiologic jaundice can be totally ruled out. It should be underscored that the color of stools and urine must be considered when examining a jaundiced infant.
New perspectives
New perspectives on treatment are mainly based upon the role of immune dysfunction in biliary atresia, which is still not fully understood, even though it has been the object of numerous studies. There is a necessity for future research into interferon-gamma, other cytokines, and regulatory T cells, which inhibit the immune response mediated by effector T cells (CD4 + CD25 + cells provide contact-dependent immunosuppression; T H 3 cells release TGF-β; and T R 1 cells produce IL-10), 108 using both animal models and humans, in order to assess whether these aspects could be potential targets for therapeutic intervention.
